Skip to main content
Fig. 4 | Renal Replacement Therapy

Fig. 4

From: Impact on change in serum beta 2 microglobulin by combination therapy of peritoneal dialysis and hemodialysis: a 12-month preliminary observational study

Fig. 4

Percentage of patients with β2 microglobulin values less than 30 mg/L after the initiation of PD + HD combination therapy over 12 months. The number of patients whose β2 microglobulin value was less than 30 was approximately 30% throughout the observation period. Cochran’s Q test did not show significant differences in the percentages of patients in each group in all the study periods (p = 0.717)

Back to article page